Tanaka M - Search Results

1

Anti-neovascular therapy using novel peptides homing to angiogenic vessels.

Oku N, Asai T, Watanabe K, Kuromi K, Nagatsuka M, Kurohane K, Kikkawa H, Ogino K, Tanaka M, Ishikawa D, Tsukada H, Momose M, Nakayama J, Taki T. Oku N, et al. Among authors: tanaka m. Oncogene. 2002 Apr 18;21(17):2662-9. doi: 10.1038/sj.onc.1205347. Oncogene. 2002. PMID: 11965539

2

Suppression of tumor growth by novel peptides homing to tumor-derived new blood vessels.

Asai T, Nagatsuka M, Kuromi K, Yamakawa S, Kurohane K, Ogino K, Tanaka M, Taki T, Oku N. Asai T, et al. Among authors: tanaka m. FEBS Lett. 2002 Jan 16;510(3):206-10. doi: 10.1016/s0014-5793(01)03265-3. FEBS Lett. 2002. PMID: 11801255 Free article.

3

Isolation of a novel peptide homing to tumor-derived neovasculature that suppresses tumor growth.

Asai T, Fukatsu H, Kuromi K, Ogino K, Tanaka M, Oku N, Taki T. Asai T, et al. Among authors: tanaka m. Biol Pharm Bull. 2002 Jul;25(7):904-6. doi: 10.1248/bpb.25.904. Biol Pharm Bull. 2002. PMID: 12132666 Free article.

4

A new approach for drug discovery from glycobiology and phage-displayed peptide library technology.

Taki T, Ishikawa D, Ogino K, Tanaka M, Oku N, Asai T, Popa I, Portoukalian J. Taki T, et al. Among authors: tanaka m. Biochim Biophys Acta. 2008 Mar;1780(3):497-503. doi: 10.1016/j.bbagen.2008.01.005. Epub 2008 Jan 16. Biochim Biophys Acta. 2008. PMID: 18241678

5

Suppression of GD1alpha ganglioside-mediated tumor metastasis by liposomalized WHW-peptide.

Takikawa M, Kikkawa H, Asai T, Yamaguchi N, Ishikawa D, Tanaka M, Ogino K, Taki T, Oku N. Takikawa M, et al. Among authors: tanaka m. FEBS Lett. 2000 Jan 28;466(2-3):381-4. doi: 10.1016/s0014-5793(00)01110-8. FEBS Lett. 2000. PMID: 10682865 Free article.

6

GD3-replica peptides selected from a phage peptide library induce a GD3 ganglioside antibody response.

Popa I, Ishikawa D, Tanaka M, Ogino K, Portoukalian J, Taki T. Popa I, et al. Among authors: tanaka m. FEBS Lett. 2006 Feb 20;580(5):1398-404. doi: 10.1016/j.febslet.2006.01.063. Epub 2006 Jan 30. FEBS Lett. 2006. PMID: 16458892 Free article.

7

Bioorganic synthesis of end-capped anti-HIV peptides by simultaneous cyanocysteine-mediated cleavages of recombinant proteins.

Tanaka M, Kajiwara K, Tokiwa R, Watanabe K, Ohno H, Tsutsumi H, Hata Y, Izumi K, Kodama E, Matsuoka M, Oishi S, Fujii N. Tanaka M, et al. Bioorg Med Chem. 2009 Nov 1;17(21):7487-92. doi: 10.1016/j.bmc.2009.09.015. Epub 2009 Sep 15. Bioorg Med Chem. 2009. PMID: 19811922

8

Development of a novel fusion inhibitor against T-20-resistant HIV-1.

Oishi S, Ito S, Nishikawa H, Tanaka M, Ohno H, Otaka A, Izumi K, Kodama E, Matsuoka M, Fujii N. Oishi S, et al. Among authors: tanaka m. Adv Exp Med Biol. 2009;611:389-91. doi: 10.1007/978-0-387-73657-0_170. Adv Exp Med Biol. 2009. PMID: 19400237 No abstract available.

9

Design of a novel HIV-1 fusion inhibitor that displays a minimal interface for binding affinity.

Oishi S, Ito S, Nishikawa H, Watanabe K, Tanaka M, Ohno H, Izumi K, Sakagami Y, Kodama E, Matsuoka M, Fujii N. Oishi S, et al. Among authors: tanaka m. J Med Chem. 2008 Feb 14;51(3):388-91. doi: 10.1021/jm701109d. Epub 2008 Jan 16. J Med Chem. 2008. PMID: 18197613

10

Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.

Kikuchi A, Tomoyasu T, Tanaka M, Kanamitsu K, Sasabe H, Maeda T, Odomi M, Tamai I. Kikuchi A, et al. Among authors: tanaka m. J Pharm Sci. 2009 May;98(5):1775-87. doi: 10.1002/jps.21551. J Pharm Sci. 2009. PMID: 18781650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,417 results

Search Page

Filters